BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

 

Search: Angiogenesis

Search : Tumor Angiogenesis and Microcirculation Tumor Angiogenesis and Microcirculation
by: Voest/Damore
This product in another region: UK | USA
Search : Angiogenesis in Health and Disease (Nato Science Series: A:) Angiogenesis in Health and Disease (Nato Science Series: A:)
from: Springer
Bioportfolio's Price: $281.00
Prices subject to change.
This product in another region: UK | USA
Search : Molecular, Cellular and Clinical Aspects of Angiogenesis (Nato Science Series: A:) Molecular, Cellular and Clinical Aspects of Angiogenesis (Nato Science Series: A:)
from: Springer
Bioportfolio's Price: $205.00
Prices subject to change.
This product in another region: UK | USA
Search : Strategies in Regenerative Medicine: Integrating Biology with Materials Design Strategies in Regenerative Medicine: Integrating Biology with Materials Design
from: Springer
Bioportfolio's Price: $99.00
Prices subject to change.
This product in another region: UK | USA
Search : Angiogenesis and Screening in Uveal Melanoma Angiogenesis and Screening in Uveal Melanoma
by: G.S.O.A. Missotten
This product in another region: UK | USA
Search : Angiogenesis (Progress in Applied Microcirculation, Vol. 4) Angiogenesis (Progress in Applied Microcirculation, Vol. 4)
from: Not Avail
Bioportfolio's Price: $40.25
Prices subject to change.
This product in another region: UK | USA
Search : Angiogenesis targeted in rheumatoid arthritis: numerous inhibitors in pipeline.(Rx): An article from: Family Practice News Angiogenesis targeted in rheumatoid arthritis: numerous inhibitors in pipeline.(Rx): An article from: Family Practice News
by: Bruce Jancin
Bioportfolio's Price: $5.95
Prices subject to change.
This product in another region: UK | USA
Search : Novartis/Schering AG oral angiogenesis inhibitor PTK/ZK completes enrollment for key Phase III metastatic colorectal cancer trial.: An article from: BIOTECH Patent News Novartis/Schering AG oral angiogenesis inhibitor PTK/ZK completes enrollment for key Phase III metastatic colorectal cancer trial.: An article from: BIOTECH Patent News
from: Biotech Patent News
Bioportfolio's Price: $5.95
Prices subject to change.
This product in another region: UK | USA
Search : Handbook of Myocardial Revascularization and Angiogenesis Handbook of Myocardial Revascularization and Angiogenesis
by: Martin B Leon, Ran Kornowski, Stephen E Epstein
Bioportfolio's Price: $159.95
Prices subject to change.
This product in another region: UK | USA
Search : Fibrinolysis and angiogenesis in wound healing: Highlights of the 2nd international forum, San Antonio, Texas, December 4, 1987 Fibrinolysis and angiogenesis in wound healing: Highlights of the 2nd international forum, San Antonio, Texas, December 4, 1987
from: Excerpta Medica
This product in another region: UK | USA

page 4 of  14
 1  2  3  4  5  6  7  8  9  10  11 
 


Competitive Outlook on Anti-Angiogenesis and Vascular Targeting in ...
Information on most companies active in anti-angiogenesis and vascular ... Producing presentations surrounding the development of anti-angiogenesis and ...
http://www.bioportfolio.com/cgi-bin/acatalog/Competitive_Out...

BioPortfolio - Biocorporate Search Angiogenesis1
Collateral's initial non-surgical gene therapy products under investigation are designed to promote and enhance angiogenesis, a natural biological process ...
http://www.bioportfolio.com/biocorporate/Angiogenesis-compan...

ATN-161, and integrin antagonists that reduces angiogenesis and ...
Angiogenesis, the formation of new blood vessels, is crucial to a number of ... Hence ATN-161 effectively reduced tumor angiogenesis and furthermore it also ...
http://www.bioportfolio.com/LeadDiscovery/PubMed-030319.html...

Adiponectin limits tumor angiogenesis-the missing link between ...
Tumor vascularization is key to the development of solid tumors and the vast majority of pharmaceutical activity surrounding angiogenesis relates to the ...
http://www.bioportfolio.com/news/DailyUpdates_12.htm...

CD146, a target for the inhibition of angiogenesis
Angiogenesis, the formation of new blood vessels, is crucial to a number of ... Consequently angiogenesis represents an emerging therapeutic target which by ...
http://www.bioportfolio.com/LeadDiscovery/PubMed-040311.html...

Antibodies to PlGF as anti-angiogenesis therapies for cancer ...
In addition Sugen have a variety of information relating to angiogenesis at their ..... Anti-PlGF antibody as a candidate anti-angiogenic molecule with ...
http://www.bioportfolio.com/LeadDiscovery/thr008.htm...

BioPortfolio - BioPortfolio - Angiogenesis Technologies Incorporated
BioPortfolio - Angiogenesis Technologies Incorporated - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/linkout/808/www.ang...

Inhibition of angiogenesis as a new treatment modality
BioPortfolio the comprehensive website for data, information, search engine and services on biotechnology, pharmaceutical and healthcare research, ...
http://www.bioportfolio.com/news/leaddiscovery_10.htm...

BioPortfolio - Angiogenesis Technologies Incorporated
Angiogenesis Technologies Incorporated - BioPortfolio.
http://www.bioportfolio.com/search/Angiogenesis_Technologies...

Arteriogenesis as a treatment of stroke
Angiogenesis represents an emerging therapeutic target which by 2006, is expected to command a market of $1.75 billion. A growing component of this market ...
http://www.bioportfolio.com/LeadDiscovery/PubMed-090309.html...

Recent Searches for Books on Bioportfolio:

| huntingtons disease more:tests_diagnosis | Craig A. Madden, F.Norman Thompson | Modern Molecular Photochemistry turro | Modern Molecular Photochemistry turro | cynthia roach haack | Drugs in Prehistory | Drugs in Prehistory | Joseph T. Wells james wells | 0870814117 | 0870814117 | PDF Drug Information Handbook | PDF Drug Information Handbook | 067343205x 200 29244 | the brave little computer |
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.